𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Prolongation of levodopa responses by glycineB antagonists in parkinsonian primates

✍ Scribed by Stella M. Papa; Yves P. Auberson; J. Timothy Greenamyre

Book ID
101466450
Publisher
John Wiley and Sons
Year
2004
Tongue
English
Weight
163 KB
Volume
56
Category
Article
ISSN
0364-5134

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The α2 adrenergic antagonist fipamezole
The α2 adrenergic antagonist fipamezole improves quality of levodopa action in Parkinsonian primates
✍ Tom H. Johnston; Susan H. Fox; Matthew J. Piggott; Juha-Matti Savola; Jonathan M 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 402 KB

## Abstract Reduction in the antiparkinsonian benefit of levodopa is a major complication of long‐term levodopa treatment in advanced Parkinson's disease (PD). Such loss of benefit arises because of reduced duration of action and appearance of disabling dyskinesia. We assess the potential of the α~

Prevention of levodopa-induced dyskinesi
Prevention of levodopa-induced dyskinesias by a selective NR1A/2B N-methyl-D-aspartate receptor antagonist in parkinsonian monkeys: Implication of preproenkephalin
✍ Marc Morissette; Mehdi Dridi; Frédéric Calon; Abdallah Hadj Tahar; Leonard T. Me 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 175 KB

## Abstract Enkephalin is reported to play an important role in the pathophysiology of levodopa (LD) ‐induced dyskinesias. The present study investigated the effect of chronic treatment with a selective NR1A/2B __N__‐methyl‐D‐aspartate (NMDA) receptor antagonist, CI‐1041, on the expression of prepr